FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY

Today's Daily Dose brings you news about the progress in Flexion Therapeutics' pipeline; Immunome's coronavirus research program; Pfizer/BioNTech testing COVID-19 vaccine in pregnant women; and Rigel's deal with Lilly to develop RIPK1 inhibitors.